Flurbiprofen (ophthalmic)

From Drugs Prescribing Information
Jump to: navigation, search

Contents

[edit] BRAND NAMES

  • International: Ocufen ophthalmic solution 0.03%
  • Italy: Ocufen

[edit] STRUCTURE

Flurbiprofen.jpg

[edit] MECHANISM OF ACTION

Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) that has anti-inflammatory activity. The mechanism of its action is thought to be due to its ability to block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2. Prostaglandins have been shown in many animal models to be mediators of certain kinds of intraocular inflammation.

[edit] INDICATIONS

  • Flurbiprofen ophthalmic solution is indicated for the inhibition of intraoperative miosis.

[edit] DOSAGE

A total of four (4) drops of Flurbiprofen ophthalmic solution should be administered by instilling one (1) drop approximately every 1/2 hour beginning 2 hours before surgery.

[edit] CONTRAINDICATIONS

  • Flurbiprofen ophthalmic solution is contraindicated in individuals who are hypersensitive to any components of

the medication.

[edit] WARNINGS AND PRECAUTIONS

Cross-Sensitivity or Hypersensitivity

There is the potential for cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, and other NSAIDs. Therefore, caution should be used when treating individuals who have previously exhibited sensitivities to these drugs.

Increased Bleeding Time

With some NSAIDs, there exists the potential for increased bleeding time due to interference with thrombocyte aggregation. There have been reports that ocularly applied nonsteroidal anti-inflammatory drugs may cause increased bleeding of ocular tissues (including hyphemas) in conjunction with ocular surgery. It is recommended that Flurbiprofen ophthalmic solution be used with caution in patients with known bleeding tendencies or who are receiving other medications, which may prolong bleeding time.

[edit] PREGNANCY AND LACTATION

  • Pregnancy Category C (US). Flurbiprofen ophthalmic solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
  • Nursing Mothers: It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from flurbiprofen sodium, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

[edit] SIDE EFFECTS

Transient burning and stinging upon instillation and other minor symptoms of ocular irritation have been reported. Other adverse reactions include: fibrosis, hyphema, miosis, mydriasis, and ocular hyperemia. Increased bleeding tendency of ocular tissues in conjunction with ocular surgery has also been reported

[edit] RELATED LINKS

[edit] BIBLIOGRAPHY

[edit] REFERENCES

[[Category:Ophthalmic_NSAIDs]]

Non-steroidal anti-inflammatory drugs (NSAIDs)
Non-selective (COX-1 and COX-2 inhibitors) Aceclofenac   Acetylsalicylic acid   Benzydamine   Diclofenac   Flurbiprofen   Ibuprofen   Indometacin   Ketoprofen   Ketorolac   Ketorolac   Lornoxicam   Mefenamic acid   Morniflumate   Nabumetone   Naproxen   Niflumic acid   Piroxicam   Tenoxicam
Relatively COX-2 selective Meloxicam   Nimesulide
COX-2 selective inhibitors (Coxibs) Celecoxib   Etoricoxib   Parecoxib
Ophthalmic NSAIDs Bromfenac (ophthalmic)   Diclofenac (ophthalmic)   Flurbiprofen (ophthalmic)   Ketorolac (ophthalmic)   Nepafenac (ophthalmic)
Veterinary use Carprofen   Deracoxib   Firocoxib   Mavacoxib   Robenacoxib